Camosten™ - References

I Product Info I Ingredients I Recommended Use I Clinical Trials I Research Brief I References

camostenl

 

Order this item

Low USA domestic & international

shipping

Indication: bone and teeth strengthening, calcium deficiency, to prevent rickets and osteoporosis, bone fractures, caries, nail fragility, impaired neuromuscular transmission, pregnancy and lactation.

Actions: prevents osteoporosis, strengthens the bone tissues, promotes bone fracture healing, promotes normal growth and development of children, prevents rickets, strengthens the teeth, improves neuromuscular transmission.

Ingredients (per 1 packet – 6.6 g):

Vitamin D (as cholecalciferol) - 80 IU, calcium (as dicalcium phosphate and calcium citrate - 500 mg, magnesium (as magnesium citrate) - 200.0 mg, manganese (as manganese gluconate) - 0.2 mg.

Camosten™ - References:

1. Chevalley T., Rizzoli R., Nydegger V., et al. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin D-repleted elderly patients. Osteoporosis Int. 1994;4:245-52.
2. Dawson-Hughes B. Calcium, vitamin D and vitamin D metabolites. Osteoporosis 1996. Ed. S.E. Papapoulos et al. Elsevier. Amsterdam, Lausanne, New York. 1996; 299-303.
3. Bostick RM, Kushi LH, Wu Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999; 149:151-61.
4. Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med 1992;152:2441-4.
5. Shils ME. Modern Nutrition in Health and Disease. 9th ed. Baltimore: Williams & Wilkins, 1999.
6. Riggs BL, Melton L. The worldwide problem of osteoporosis: Insights afforded by epidemiology. Bone 1995;17:505S-511S.
7. National Osteoporosis Foundation. NOF osteoporosis prevention - risk factors for osteoporosis. 2003.
8. Rouse IL, Beilin LJ, Armstrong BK, Vandongen R. Blood-pressure-lowering effect of a vegetarian diet: controlled trial in normotensive subjects. Lancet 1983;1:5-10.
9. Margetts BM, Beilin L, Armstrong BK, Vandongen R. Vegetarian diet in the treatment of mild hypertension: a randomized controlled trial. J Hypertens 1985:S429-31.
10. Beilin LJ, Armstrong BK, Margetts BM, Rouse IL, Vandongen R. Vegetarian diet and blood pressure. Nephron 1987;47:37-41.
11. Allender PS, Cutler JA, Follmann D, Cappuccio FP, Pryer J, Elliott P. Dietary calcium and blood pressure. Ann Intern Med 1996;124:825-831.
12. Bucher HC, Cook RJ, Guyatt GH, et al. Effects of dietary calcium supplementation on blood pressure. JAMA 1996;275:1016-1022.
13. Davies KM, Heaney RP, Recker RR, Lappe JM, Barger-Lux MJ, Rafferty K, Hinders S. Calcium intake and body weight. J. Clin Endocrinol Metab 2000;85:4635-8.
14. Heaney RP. Normalizing calcium intake: projected population effects for body weight. J Nutr 2003;133:268S-70S.
15. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr 2002;21:146S-51S.
16. Calcium Plus Vitamin D Supplementation and the Risk of Postmenopausal Weight Gain
Arch Intern Med. 2007;167:893-902
17. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004;79(3):362-371. (PubMed)
18. Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003;23:117-145. (PubMed)
19. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 2003;17(3):509-511. (PubMed)
20. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003;57(4):258-261. (PubMed)
21. Heaney RP. Long-latency deficiency disease: insights from calcium and vitamin D. Am J Clin Nutr 2003;78:912-9
22. Parfitt AM. Osteomalacia and related disorders. In: Avioli LV, Krane SM, etc. Metabolic bone disease and clinically related disorders. 2nd ed. Philadelphia: WB Saunders. 1990:329-96
23. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. J Am Med Assoc 1999;251:1505-11
24. Posner G. Low-Calcemic Vitamin D Analogs (Deltanoids) for Human Cancer Prevention. J. Nutr 2002;132:3802S-3S.
25. Martinez ME and Willett W C. Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol. Biomark. Prev 1998;7:163-68.
26. Sakhaee K, Poindexter JR, Griffith CS, Pak CY. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. J Urol. 2004 Sep;172(3):958-61.
27. Joan M Lappe, Dianne Travers-Gustafson, K Michael Davies, Robert R Recker and Robert P Heaney Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial
28. Heller HJ, Stewart A, Haynes S, et al. Pharmacokinetics of calcium absorption from two commercial calcium supplements. J Clin Pharmacol. 1999;39:1151–1154.
29. Tuck SP, Datta HK. Osteoporosis in the aging male: treatment options. Clin Interv Aging. 2007;2(4):521-36.
30. Gennari C. Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutr. 2001 Apr;4(2B):547-59.
31. Masi L, Bilezikian JP. Osteoporosis: new hope for the future. Int J Fertil Womens Med. 1997 Jul-Aug;42(4):245-54.